Cargando…
Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin
BACKGROUND: Bacterial biofilms readily develop on all medical implants, including percutaneous osseointegrated (OI) implants. With the growing rate of antibiotic resistance, exploring alternative options for managing biofilm-related infections is necessary. Antimicrobial blue light (aBL) is a unique...
Autores principales: | Ong, Jemi, Godfrey, Rose, Nazarian, Alexa, Tam, Joshua, Isaacson, Brad M., Pasquina, Paul F., Williams, Dustin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248220/ https://www.ncbi.nlm.nih.gov/pubmed/37303789 http://dx.doi.org/10.3389/fmicb.2023.1158558 |
Ejemplares similares
-
An antimicrobial blue light device to manage infection at the skin-implant interface of percutaneous osseointegrated implants
por: Ong, Jemi, et al.
Publicado: (2023) -
Determining the Antibiofilm Efficacy of Oregano Gel in an Ex Vivo Model of Percutaneous Osseointegrated Implants
por: Ong, Jemi, et al.
Publicado: (2022) -
Comparing the Synergistic and Antagonistic Interactions of Ciprofloxacin and Levofloxacin Combined with Rifampin against Drug-Resistant Staphylococcus aureus: A Time–Kill Assay
por: Kang, Yu Ri, et al.
Publicado: (2023) -
Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
por: Huang, Yu-Tsung, et al.
Publicado: (2018) -
Ultrasonically enhanced rifampin activity against internalized Staphylococcus aureus
por: SHI, SI-FENG, et al.
Publicado: (2013)